News
Mitsubishi Research Institute and Astellas have agreed on a memorandum of understanding to provide drug-discovery startups in ...
Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...
TekniPlex Healthcare has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
Cryoport Inc. has completed the previously announced divestiture of its specialty courier business, CRYOPDP, to DHL Group.
The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...
Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to ...
How the effectiveness, flexibility and sustainability of single-use technologies solve many of today’s challenges in ...
BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines.
Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.
OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...
Schreiner MediPharm, a global provider of functional label solutions for the healthcare industry, has introduced the Smart ...
PL BioScience GmbH, a German life science company, has appointed Oliver Dick, PhD, as Chief Technology Officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results